You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 7,371,844

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,371,844

Title:	Nucleic acids encoding parathyroid hormone (PTH) derivatives
Abstract:	Parathyroid hormone(PTH) polypeptide derivatives are disclosed, as are pharmaceutical compositions containing said polypeptides, and synthetic and recombinant methods for producing said polypeptides. Also disclosed are methods for treating mammalian conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions containing said polypeptides. Also disclosed are methods for screening candidate compounds of the invention for antagonistic or agonistic effects on parathyroid hormone receptor action. Also disclosed are diagnostic and therapeutic methods of said compounds.
Inventor(s):	Gardella; Thomas J. (Needham, MA), Kronenberg; Henry M. (Belmont, MA), Potts, Jr.; John T. (Newton, MA), Juppner; Harald (Cambridge, MA)
Assignee:	The General Hospital Corporation (Boston, MA)
Application Number:	11/176,735
Patent Claims:	1. An isolated nucleic acid molecule encoding a biologically active polypeptide consisting of the amino acid sequence AlaValAlaGluIIeGInLeuMetHisX01X02X03LysX04 (SEQ ID NO: 1), wherein: X01 is Ala, Asp or Gin; X02 is Leu, Arg or homoArg; X03 is Arg or Ala; and X04 is Phe or Trp; and wherein said polypeptide binds to a Parathyroid hormone-1 (PTH-1) receptor. 2. A recombinant DNA molecule comprising: (1) an expression control region, said region operably linked to (2) the nucleotide molecule of claim 1. 3. A method of preparing a polypeptide, comprising introducing the recombinant DNA of claim 2 into a host cell and expressing the polypeptide encoded by said nucleic acid. 4. The recombinant DNA molecule of claim 2, wherein said control region includes a bacterial, viral, fungal or mammalian promoter. 5. A prokaryotic or eukaryotic isolated host cell containing the recombinant DNA molecule of claim 2. 6. The cell of claim 5 which is bacterial. 7. The cell of claim 5 which is a yeast cell or a mammalian cell. 8. A method for making a recombinant vector comprising inserting a nucleic acid molecule of claim 1 into a vector.

Details for Patent 7,371,844

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2020-02-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.